JPS5995300A - コントロ−ルされた粒度の２−シアノ−４，５−エポキシ−３−オキソ−ステロイド類およびそれらの組成物 - Google Patents
コントロ−ルされた粒度の２−シアノ−４，５−エポキシ−３−オキソ−ステロイド類およびそれらの組成物Info
- Publication number
- JPS5995300A JPS5995300A JP58202482A JP20248283A JPS5995300A JP S5995300 A JPS5995300 A JP S5995300A JP 58202482 A JP58202482 A JP 58202482A JP 20248283 A JP20248283 A JP 20248283A JP S5995300 A JPS5995300 A JP S5995300A
- Authority
- JP
- Japan
- Prior art keywords
- cyano
- granular
- epoxy
- trilostane
- particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8231278 | 1982-11-02 | ||
| GB8231278 | 1982-11-02 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5995300A true JPS5995300A (ja) | 1984-06-01 |
| JPH0443078B2 JPH0443078B2 (enExample) | 1992-07-15 |
Family
ID=10533991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58202482A Granted JPS5995300A (ja) | 1982-11-02 | 1983-10-28 | コントロ−ルされた粒度の２−シアノ−４，５−エポキシ−３−オキソ−ステロイド類およびそれらの組成物 |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0108606B1 (enExample) |
| JP (1) | JPS5995300A (enExample) |
| AT (1) | ATE38236T1 (enExample) |
| DE (1) | DE3378318D1 (enExample) |
| DK (1) | DK499683A (enExample) |
| ES (1) | ES526874A0 (enExample) |
| FI (1) | FI834025L (enExample) |
| GB (1) | GB2130588B (enExample) |
| GR (1) | GR79688B (enExample) |
| IE (1) | IE56205B1 (enExample) |
| NO (1) | NO833976L (enExample) |
| PT (1) | PT77593B (enExample) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003520803A (ja) * | 2000-01-18 | 2003-07-08 | マーゲツツ，ジヨージ | ホルモンレセプターの調節 |
| JP2004529142A (ja) * | 2001-04-09 | 2004-09-24 | ステグラム・ファーマシューティカルズ・リミテッド | ヒトおよび動物におけるコルチゾールおよび他の副腎ホルモンの異常濃度に伴う臨床状態の処置としてのこれらのホルモン濃度の間歇的低下 |
| JP2006523665A (ja) * | 2003-04-16 | 2006-10-19 | マーゲッツ，ジョージ | アンギオテンシンｉｉ関連疾患の治療 |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8328929D0 (en) * | 1983-10-29 | 1983-11-30 | Sterwin Ag | Steroid compounds |
| US6458811B1 (en) | 1996-03-26 | 2002-10-01 | Eli Lilly And Company | Benzothiophenes formulations containing same and methods |
| JP5544458B2 (ja) | 2005-07-12 | 2014-07-09 | アンピオ ファーマシューティカルズ，インコーポレイテッド | 疾病を治療するための医薬製品の製造においてトリロスタンｉｉｉを使用する方法及びトリロスタンｉｉｉを含む医薬製品 |
| GB2627797A (en) * | 2023-03-02 | 2024-09-04 | Norbrook Lab Ltd | Trilostane formulation |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1123770A (en) * | 1966-11-15 | 1968-08-14 | Sterling Drug Inc | 2-cyano-3-oxo-steroids |
| US3296255A (en) * | 1963-11-29 | 1967-01-03 | Sterling Drug Inc | 2-cyano steroids |
| FR2408345A1 (fr) * | 1976-11-30 | 1979-06-08 | Besins Jean Louis | Nouvelle composition a action anti-conceptionnelle |
| US4062954A (en) * | 1976-12-27 | 1977-12-13 | Sterling Drug Inc. | Process for using a steroid compound |
| US4160027A (en) * | 1977-12-20 | 1979-07-03 | Sterling Drug Inc. | Steroid cyanoketones and intermediates |
| GB8328929D0 (en) | 1983-10-29 | 1983-11-30 | Sterwin Ag | Steroid compounds |
-
1983
- 1983-10-28 JP JP58202482A patent/JPS5995300A/ja active Granted
- 1983-10-28 ES ES526874A patent/ES526874A0/es active Granted
- 1983-11-01 GB GB08329173A patent/GB2130588B/en not_active Expired
- 1983-11-01 NO NO833976A patent/NO833976L/no unknown
- 1983-11-01 DK DK499683A patent/DK499683A/da not_active Application Discontinuation
- 1983-11-02 EP EP83306665A patent/EP0108606B1/en not_active Expired
- 1983-11-02 GR GR72848A patent/GR79688B/el unknown
- 1983-11-02 DE DE8383306665T patent/DE3378318D1/de not_active Expired
- 1983-11-02 IE IE2563/83A patent/IE56205B1/en not_active IP Right Cessation
- 1983-11-02 AT AT83306665T patent/ATE38236T1/de not_active IP Right Cessation
- 1983-11-02 FI FI834025A patent/FI834025L/fi not_active Application Discontinuation
- 1983-11-02 PT PT77593A patent/PT77593B/pt not_active IP Right Cessation
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003520803A (ja) * | 2000-01-18 | 2003-07-08 | マーゲツツ，ジヨージ | ホルモンレセプターの調節 |
| JP2004529142A (ja) * | 2001-04-09 | 2004-09-24 | ステグラム・ファーマシューティカルズ・リミテッド | ヒトおよび動物におけるコルチゾールおよび他の副腎ホルモンの異常濃度に伴う臨床状態の処置としてのこれらのホルモン濃度の間歇的低下 |
| JP2006523665A (ja) * | 2003-04-16 | 2006-10-19 | マーゲッツ，ジョージ | アンギオテンシンｉｉ関連疾患の治療 |
Also Published As
| Publication number | Publication date |
|---|---|
| FI834025A0 (fi) | 1983-11-02 |
| PT77593B (en) | 1986-03-18 |
| EP0108606A1 (en) | 1984-05-16 |
| IE56205B1 (en) | 1991-05-22 |
| EP0108606B1 (en) | 1988-10-26 |
| GR79688B (enExample) | 1984-10-31 |
| GB8329173D0 (en) | 1983-12-07 |
| DK499683D0 (da) | 1983-11-01 |
| JPH0443078B2 (enExample) | 1992-07-15 |
| FI834025A7 (fi) | 1984-05-03 |
| GB2130588B (en) | 1986-08-13 |
| DK499683A (da) | 1984-05-03 |
| ES8504486A1 (es) | 1985-05-01 |
| FI834025L (fi) | 1984-05-03 |
| IE832563L (en) | 1984-05-02 |
| GB2130588A (en) | 1984-06-06 |
| ATE38236T1 (de) | 1988-11-15 |
| DE3378318D1 (en) | 1988-12-01 |
| ES526874A0 (es) | 1985-05-01 |
| PT77593A (en) | 1983-12-01 |
| NO833976L (no) | 1984-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100911790B1 (ko) | 미세화 프로게스테론을 주성분으로 하는 제약 조성물,그의 제조 방법 및 그의 용도 | |
| RU2148992C1 (ru) | Способ кондиционирования веществ | |
| JP4187423B2 (ja) | ジプラシドン組成物 | |
| KR0126465B1 (ko) | 난용성 약물의 초미립자화 방법 및 초미립자상 약물을 함유하는 제제 | |
| EP1487832B2 (de) | Kristallines mikronisat des tiotropiumbromids | |
| EP1326585A2 (de) | Verfahren zur herstellung von pulverformulierungen | |
| EP1429722B1 (de) | Aufstreuverfahren zur herstellung von pulverformulierungen | |
| JP2013516394A (ja) | 医薬用途用の１−（１ｈ−１，２，４−トリアゾール−１−イル）ブタン−２−オール誘導体、および前記１−（１ｈ−１，２，４−トリアゾール−１−イル）ブタン−２−オール誘導体を調製するための、実質的に不定の結晶形状を有する１−（１ｈ−１，２，４−トリアゾール−１−イル）ブタン−２−オール誘導体の使用 | |
| JPS5995300A (ja) | コントロ−ルされた粒度の２−シアノ−４，５−エポキシ−３−オキソ−ステロイド類およびそれらの組成物 | |
| Rudén et al. | On the relationship between blend state and dispersibility of adhesive mixtures containing active pharmaceutical ingredients | |
| CN111494558A (zh) | 一种新的强力定眩胶囊及其制备方法 | |
| Pawar et al. | Liquisolid compacts: A promising approach for solubility enhancement | |
| CN108669531A (zh) | 一种金钗石斛粉末及其应用 | |
| CN108066312B (zh) | 一种帕博西尼药物组合物及其制备方法 | |
| CN101884791B (zh) | 一种来曲唑共研磨物及其制备方法和含其药物组合物 | |
| JPH035483A (ja) | 薬学的組成物 | |
| Sharma et al. | Formulation, evaluation and optimization of mouth dissolving tablets of losartan potassium: effect of coprocessed superdisintegrants | |
| CN116194087B (zh) | 一种含茚达特罗的吸入气雾剂药物组合物及其制备方法 | |
| Jadhav et al. | Liquisolid technique a novel approach to enhance solubility and dissolution rate: a review | |
| Kumre et al. | Formulation and Evaluation of Antiplatelet Clopidogrel Tablet using β-cyclodextrin for Solubility Enhancement | |
| CN104382936B (zh) | 一种磺化去氢松香酸铋的口服固体制剂及其制备方法 | |
| Meghana et al. | FORMULATION AND EVALUATION OF FAST DISSOLVING TABLETS OF CHARANTIN USING TWO DIFFERENT TECHNUQUES | |
| CN105395554B (zh) | 一种叶酸固体分散体及其制备方法 | |
| CN109674773A (zh) | 一种肺部给药的昔多芬药物微粒及其制备方法与应用 | |
| Sundari et al. | Formulation and evaluation of SMEDDS containing ezetimibe by employing arachis oil as oil and Tween 80, Peg 400 as surfactant system |